MODIFICATION TO ABUSCREEN ONLINE FOR AMPHETAMINES— 510(k) K983699

Substantially Equivalent

Roche Diagnostic Systems, Inc.

FDA 510(k) clearance K983699 for MODIFICATION TO ABUSCREEN ONLINE FOR AMPHETAMINES, Substantially Equivalent on 1998-12-11. Applicant: Roche Diagnostic Systems, Inc..

Clearance details

Applicant: Roche Diagnostic Systems, Inc.
Product code: Code DKZ
Advisory panel: Clinical Toxicology
Date received: 1998-10-21
Decision date: 1998-12-11
Decision: Substantially Equivalent
Clearance type: Special
Location: Somerville, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.